These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 720075)

  • 1. Clinical trial with subdermal implants containing norgestrienone.
    Diaz S; Pavez M; Quinteros E; Diaz J; Robertson DN; Croxatto HB
    Contraception; 1978 Oct; 18(4):429-40. PubMed ID: 720075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eighteen months contraception following subdermal insertion of silastic capsules containing norgestrienone.
    Da Silva AR; Coutinho EM
    Int J Fertil; 1978; 23(3):185-92. PubMed ID: 40892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical chemistry in women treated with progestogen implants.
    Croxatto HB; Diaz S; Pavez M
    Contraception; 1978 Oct; 18(4):441-50. PubMed ID: 720076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravaginal contraception with the synthetic progestin, R2010.
    Toivonen J
    Contraception; 1979 Nov; 20(5):511-8. PubMed ID: 527342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contraceptive effectiveness of Silastic implants containing the progestin R-2323.
    Coutinho EM; Da Silva AR; Carreira CM; Chaves MC; Adeodato Filho J
    Contraception; 1975 Jun; 11(6):625-35. PubMed ID: 1137935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with implant contraception.
    Coutinho E
    Contraception; 1978 Oct; 18(4):411-27. PubMed ID: 720074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraceptive efficacy of once-weekly oral administration of 2.5 mg R 2323.
    Sakiz E; Azadian-Boulanger G; Ojasoo T; Laraque F
    Contraception; 1976 Sep; 14(3):275-84. PubMed ID: 975818
    [No Abstract]   [Full Text] [Related]  

  • 8. Release of contraceptive steroids from sustained release dosage forms and resulting plasma levels.
    Nash HA; Robertson DN; Jackanicz TM
    Contraception; 1978 Oct; 18(4):395-409. PubMed ID: 720073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraception with long acting subdermal implants: I. An effective and acceptable modality in international clinical trials.
    Coutinho E; da Silva AR; Mattos CE; Nielsen NC; Osler M; Wiese J
    Contraception; 1978 Oct; 18(4):315-33. PubMed ID: 363345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long acting contraceptive implants. An analysis of menstrual bleeding patterns.
    Faundes A; Sivin I; Stern J
    Contraception; 1978 Oct; 18(4):355-65. PubMed ID: 363347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraception with long acting subdermal implants: II. Measured and perceived effects in international clinical trials.
    Coutinho E; da Silva AR; Mattos CE; Nielsen NC; Osler M; Wiese J
    Contraception; 1978 Oct; 18(4):335-53. PubMed ID: 363346
    [No Abstract]   [Full Text] [Related]  

  • 12. Contraceptive steroid administration by subdermal implants: serum concentrations of R-2323, estrogen and progesterone in rhesus monkeys.
    Bahgat MR; Atkinson LE
    Contraception; 1977 Mar; 15(3):335-45. PubMed ID: 880812
    [No Abstract]   [Full Text] [Related]  

  • 13. Steroid release from silastic capsules and rods.
    Nash HA; Robertson DN; Moo Young AJ; Atkinson LE
    Contraception; 1978 Oct; 18(4):367-94. PubMed ID: 720072
    [No Abstract]   [Full Text] [Related]  

  • 14. A three-year clinical trial with levonorgestrel silastic implants.
    Diaz S; Pavez M; Robertson DN; Croxatto HB
    Contraception; 1979 Jun; 19(6):557-73. PubMed ID: 385243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-year experience with NORPLANT subdermal contraception.
    Sivin I; Sanchez FA; Diaz S; Holma P; Coutinho E; McDonald O; Robertson DN; Stern J
    Fertil Steril; 1983 Jun; 39(6):799-808. PubMed ID: 6406273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
    Laurikka-Routti M; Haukkamaa M
    Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial with subdermal implants of the progestin R-2323.
    Diaz S; Pavez M; Quniteros E; Robertson DN; Croxatto HB
    Contraception; 1977 Aug; 16(2):155-65. PubMed ID: 913113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of clinical contraceptive efficacy of large doses of r 2323 given before implantation or after a missed period.
    Mora G; Faúndes A; Johansson ED
    Contraception; 1975 Aug; 12(2):211-20. PubMed ID: 1139957
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormonal implants: contraception for a new century.
    Darney PD
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years.
    Barbosa I; Coutinho E; Hirsch C; Ladipo O; Olsson SE; Ulmsten U
    Fertil Steril; 1996 Apr; 65(4):724-9. PubMed ID: 8654629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.